002275 桂林三金
交易中 07-11 14:18:12
资讯
新帖
简况
研报掘金丨中邮证券:桂林三金盈利能力稳步提升,维持“买入”评级
格隆汇 · 07-02
研报掘金丨中邮证券:桂林三金盈利能力稳步提升,维持“买入”评级
桂林三金:截至2025年06月30日股东总户数为18764
证券之星 · 07-02
桂林三金:截至2025年06月30日股东总户数为18764
调研速递|桂林三金接受天风证券等2家机构调研 业绩增长与业务布局引关注
新浪证券-红岸工作室 · 06-27
调研速递|桂林三金接受天风证券等2家机构调研 业绩增长与业务布局引关注
桂林三金:6月24日接受机构调研,中邮证券、博时基金参与
证券之星 · 06-26
桂林三金:6月24日接受机构调研,中邮证券、博时基金参与
桂林三金:截至2025年06月20日股东总户数为18097
证券之星 · 06-24
桂林三金:截至2025年06月20日股东总户数为18097
单抗概念盘中跳水,桂林三金跌1.18%
市场透视 · 06-19
单抗概念盘中跳水,桂林三金跌1.18%
【私募调研记录】永安国富调研桂林三金
证券之星 · 06-16
【私募调研记录】永安国富调研桂林三金
桂林三金:截至2025年06月10日股东总户数为18166
证券之星 · 06-13
桂林三金:截至2025年06月10日股东总户数为18166
桂林三金:宝船多个项目管线仍处于新药研发阶段
证券之星 · 06-10
桂林三金:宝船多个项目管线仍处于新药研发阶段
桂林三金:6月6日进行路演,长江证券参与
证券之星 · 06-09
桂林三金:6月6日进行路演,长江证券参与
桂林三金:6月4日接受机构调研,国盛医药、易方达等多家机构参与
证券之星 · 06-06
桂林三金:6月4日接受机构调研,国盛医药、易方达等多家机构参与
桂林三金:截至2025年05月30日股东总户数为17962
证券之星 · 06-03
桂林三金:截至2025年05月30日股东总户数为17962
每周股票复盘:桂林三金(002275)股东户数增加,业绩稳步增长
证券之星 · 05-31
每周股票复盘:桂林三金(002275)股东户数增加,业绩稳步增长
桂林三金:截至2025年05月20日股东总户数为18041
证券之星 · 05-26
桂林三金:截至2025年05月20日股东总户数为18041
桂林三金:王许飞先生在桂林三金的任职已任期届满离任
证券之星 · 05-16
桂林三金:王许飞先生在桂林三金的任职已任期届满离任
桂林三金:王许飞已于2022年12月27日任期届满离任上市公司职务
金融界 · 05-16
桂林三金:王许飞已于2022年12月27日任期届满离任上市公司职务
桂林三金:5月9日进行路演,平安证券、东方证券等多家机构参与
证券之星 · 05-12
桂林三金:5月9日进行路演,平安证券、东方证券等多家机构参与
桂林三金(002275)4月30日股东户数1.78万户,较上期增加0.61%
证券之星 · 05-06
桂林三金(002275)4月30日股东户数1.78万户,较上期增加0.61%
桂林三金最新公告:控股孙公司BC006单抗注射液新增适应症获得药物临床试验批准
证券之星 · 05-05
桂林三金最新公告:控股孙公司BC006单抗注射液新增适应症获得药物临床试验批准
桂林三金(002275.SZ):BC006单抗注射液新增适应症获药物临床试验批准
智通财经网 · 05-05
桂林三金(002275.SZ):BC006单抗注射液新增适应症获药物临床试验批准
加载更多
公司概况
公司名称:
桂林三金药业股份有限公司
所属行业:
医药制造业
上市日期:
2009-07-10
主营业务:
桂林三金药业股份有限公司的主营业务是中成药的研发、制造与销售,同时涵盖化学药品、生物药、日化健康与大健康等多个细分行业。公司的主要产品是三金片、三金颗粒、桂林西瓜霜、西瓜霜润喉片、西瓜霜清咽含片、桂林西瓜霜含片、舒咽清喷雾剂、桂林西瓜霜胶囊、脑脉泰胶囊、眩晕宁片、眩晕宁颗粒、蛤蚧定喘胶囊、复方田七胃痛胶囊、复方田七胃痛片、三七血伤宁胶囊、三七血伤宁散、复方罗汉果清肺颗粒、复方罗汉果清肺糖浆、复方红根草片、双虎肿痛宁、肝肾补颗粒、玉叶解毒颗粒。经过50多年的发展,公司质量管理体系已趋成熟,先后九次通过了澳大利亚TGA的认证复审,下属子公司均已完成新版GMP/GSP认证,并建立了覆盖全国的营销体系,公司药品质量安全可靠,产品竞争优势明显,市场空间广阔,为公司持续稳定发展夯实基础。
发行价格:
19.80
{"stockData":{"symbol":"002275","market":"SZ","secType":"STK","nameCN":"桂林三金","latestPrice":14.76,"timestamp":1752214692000,"preClose":14.85,"halted":0,"volume":3819000,"delay":0,"changeRate":-0.0061,"floatShares":559000000,"shares":588000000,"eps":0.8958,"marketStatus":"交易中","change":-0.09,"latestTime":"07-11 14:18:12","open":14.82,"high":14.9,"low":14.71,"amount":56422800,"amplitude":0.0128,"askPrice":14.76,"askSize":459,"bidPrice":14.75,"bidSize":60,"shortable":0,"etf":0,"ttmEps":0.8958,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1752217200000},"marketStatusCode":2,"adr":0,"adjPreClose":14.85,"symbolType":"stock","openAndCloseTimeList":[[1752197400000,1752204600000],[1752210000000,1752217200000]],"highLimit":16.34,"lowLimit":13.37,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":587568600,"isCdr":false,"pbRate":2.79,"roa":"--","peRate":16.476892,"roe":"3.41%","epsLYR":0.89,"committee":0.206993,"marketValue":8673000000,"turnoverRate":0.0068,"status":1,"floatMarketCap":8251000000},"requestUrl":"/m/hq/s/002275","defaultTab":"news","newsList":[{"id":"2548867226","title":"研报掘金丨中邮证券:桂林三金盈利能力稳步提升,维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2548867226","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548867226?lang=zh_cn&edition=full","pubTime":"2025-07-02 17:23","pubTimestamp":1751448182,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["09939","BK1574","BK1161","BK0060","BK0028","BK1515","002275","BK0239","161027","BK0188","159938"],"gpt_icon":0},{"id":"2548565988","title":"桂林三金:截至2025年06月30日股东总户数为18764","url":"https://stock-news.laohu8.com/highlight/detail?id=2548565988","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548565988?lang=zh_cn&edition=full","pubTime":"2025-07-02 11:51","pubTimestamp":1751428263,"startTime":"0","endTime":"0","summary":"证券之星消息,桂林三金(002275)07月02日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年6月30日A股股东人数是多少?谢谢桂林三金回复:您好,截至2025年06月30日股东总户数为18764,谢谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070200015751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002275","BK0188","BK0239","BK0028","BK0060"],"gpt_icon":0},{"id":"2546712799","title":"调研速递|桂林三金接受天风证券等2家机构调研 业绩增长与业务布局引关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2546712799","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546712799?lang=zh_cn&edition=full","pubTime":"2025-06-27 18:20","pubTimestamp":1751019600,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会!近日,桂林三金接待了天风证券、华泰证券共2家机构的调研,就公司业绩、业务进展等方面进行了深入交流。参与单位名称为天风证券、华泰证券,共4人,上市公司接待人员为桂林三金董秘李春与证代朱烨 。2024年度,桂林三金实现营业总收入219,399.20万元,较上年同期增长1.03%;利润总额64,393.50万元,同比增长24.24%;归属于上市公司股东的净利润52,153.36万元,同比增长23.79%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigc/jgdy/2025-06-27/doc-infcphxa5981155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002275","BK0188","601162","BK0276","BK0060","BK0239","BK0028"],"gpt_icon":0},{"id":"2546273822","title":"桂林三金:6月24日接受机构调研,中邮证券、博时基金参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2546273822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546273822?lang=zh_cn&edition=full","pubTime":"2025-06-26 09:32","pubTimestamp":1750901548,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年6月26日桂林三金发布公告称公司于2025年6月24日接受机构调研,中邮证券、博时基金参与。公司披露 2024 年年度权益分派预案,拟每 10股派 3.5 元,合计派发现金红利 2.06 亿元,同时披露了2025年中期现金分红规划。桂林三金主营业务:中成药的研发、制造与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062600008115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","002275","BK0028","BK0188","161027"],"gpt_icon":0},{"id":"2545861236","title":"桂林三金:截至2025年06月20日股东总户数为18097","url":"https://stock-news.laohu8.com/highlight/detail?id=2545861236","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545861236?lang=zh_cn&edition=full","pubTime":"2025-06-24 22:36","pubTimestamp":1750775782,"startTime":"0","endTime":"0","summary":"证券之星消息,桂林三金(002275)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好!请问截止6月20号,公司的股东人数是多少?谢谢桂林三金回复:您好,截至2025年06月20日股东总户数为18097,谢谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062400039414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002275","BK0060","BK0239","BK0188","BK0028"],"gpt_icon":0},{"id":"2544321134","title":"单抗概念盘中跳水,桂林三金跌1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544321134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544321134?lang=zh_cn&edition=full","pubTime":"2025-06-19 13:11","pubTimestamp":1750309874,"startTime":"0","endTime":"0","summary":"06月19日,单抗概念盘中跳水,截至13点11分,单抗概念整体指数下跌2.01%,报2229.970点。从个股上来看,该概念的成分股中,桂林三金跌1.18%,复星医药、恒瑞医药、华兰生物跌幅居前。从资金上来看,截止发稿,单抗概念概念主力净流入为-4.64亿,其中健康元受到资金热捧,主力净流入2137.74万;拉长时间线来看,该板块近20日主力资金净流入-67.38亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619131114a711d435&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619131114a711d435&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","600380","002275","BK0012","BK0183","BK0060","BK0239","BK0188","BK0187","BK0196","600196","BK0175","BK0028","600276"],"gpt_icon":0},{"id":"2543361211","title":"【私募调研记录】永安国富调研桂林三金","url":"https://stock-news.laohu8.com/highlight/detail?id=2543361211","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543361211?lang=zh_cn&edition=full","pubTime":"2025-06-16 08:00","pubTimestamp":1750032050,"startTime":"0","endTime":"0","summary":"根据市场公开信息及6月13日披露的机构调研信息,知名私募永安国富近期对1家上市公司进行了调研,相关名单如下:1)桂林三金 调研纪要:桂林三金在销售费用方面,对一线品种费用率较低,二三线品种重点倾斜,全年销售费用率稳定。分红政策方面,公司持续实施现金分红政策,2024年分红预案为每10股派3.5元,确保投资者获得稳定回报。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2025061600000431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","BK0239","BK0188","002275"],"gpt_icon":0},{"id":"2543575702","title":"桂林三金:截至2025年06月10日股东总户数为18166","url":"https://stock-news.laohu8.com/highlight/detail?id=2543575702","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543575702?lang=zh_cn&edition=full","pubTime":"2025-06-13 11:48","pubTimestamp":1749786486,"startTime":"0","endTime":"0","summary":"证券之星消息,桂林三金(002275)06月13日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年6月10日A股股东人数是多少?谢谢桂林三金回复:您好,截至2025年06月10日股东总户数为18166,谢谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061300014475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0239","002275","BK0060"],"gpt_icon":0},{"id":"2542798395","title":"桂林三金:宝船多个项目管线仍处于新药研发阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2542798395","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542798395?lang=zh_cn&edition=full","pubTime":"2025-06-10 16:15","pubTimestamp":1749543329,"startTime":"0","endTime":"0","summary":"目前公司对宝船和白帆最大限度控制成本和费用,优化人员结构,并聘请了专业咨询公司进行专项治理,尽量减少亏损。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061000023306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0060","002275","BK0188"],"gpt_icon":0},{"id":"2542732178","title":"桂林三金:6月6日进行路演,长江证券参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2542732178","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542732178?lang=zh_cn&edition=full","pubTime":"2025-06-09 10:01","pubTimestamp":1749434515,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年6月8日桂林三金发布公告称公司于2025年6月6日进行路演,长江证券参与。基药目录公布时间由国家相关部门根据调整工作开展情况公布,目前国家暂未宣布新版基药目录公布时间。桂林三金主营业务:中成药的研发、制造与销售。桂林三金2025年一季报显示,公司主营收入4.67亿元,同比下降3.32%;归母净利润1.05亿元,同比上升4.8%;扣非净利润9767.29万元,同比上升11.61%;负债率27.69%,投资收益-35.57万元,财务费用-136.25万元,毛利率77.76%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060900004237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0188","BK0276","002275","000783","BK0060","BK0028","BK0239","BK0183"],"gpt_icon":0},{"id":"2541288851","title":"桂林三金:6月4日接受机构调研,国盛医药、易方达等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2541288851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541288851?lang=zh_cn&edition=full","pubTime":"2025-06-06 09:32","pubTimestamp":1749173533,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年6月5日桂林三金发布公告称公司于2025年6月4日接受机构调研,国盛医药、易方达、富国、前海开源参与。公司披露 2024 年年度权益分派预案,拟每 10股派 3.5 元,合计派发现金红利 2.06 亿元,同时披露了2025年中期现金分红规划。桂林三金主营业务:中成药的研发、制造与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060600006312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK1574","002275","BK0239","BK0060","BK1515","159938","09939","BK1161"],"gpt_icon":0},{"id":"2540726305","title":"桂林三金:截至2025年05月30日股东总户数为17962","url":"https://stock-news.laohu8.com/highlight/detail?id=2540726305","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540726305?lang=zh_cn&edition=full","pubTime":"2025-06-03 16:36","pubTimestamp":1748939766,"startTime":"0","endTime":"0","summary":"证券之星消息,桂林三金(002275)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年5月30日A股股东人数是多少?谢谢桂林三金回复:您好,截至2025年05月30日股东总户数为17962,谢谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060300023011.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002275","BK0028","BK0188","BK0060","BK0239"],"gpt_icon":0},{"id":"2539887697","title":"每周股票复盘:桂林三金(002275)股东户数增加,业绩稳步增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2539887697","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539887697?lang=zh_cn&edition=full","pubTime":"2025-05-31 16:00","pubTimestamp":1748678433,"startTime":"0","endTime":"0","summary":"截至2025年5月30日收盘,桂林三金报收于14.21元,较上周的14.39元下跌1.25%。本周,桂林三金5月26日盘中最高价报14.46元。桂林三金当前最新总市值83.49亿元,在中药板块市值排名29/68,在两市A股市值排名1852/5146。户均持股数量由上期的3.29万股减少至3.26万股,户均持股市值为46.9万元。公司披露2024年年度权益分派预案,拟每10股派3.5元,合计派发现金红利2.06亿元,同时披露了2025年中期现金分红规划。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025053100010508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002275","BK0188","BK0239","BK0028","BK0060"],"gpt_icon":0},{"id":"2538812788","title":"桂林三金:截至2025年05月20日股东总户数为18041","url":"https://stock-news.laohu8.com/highlight/detail?id=2538812788","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538812788?lang=zh_cn&edition=full","pubTime":"2025-05-26 15:06","pubTimestamp":1748243182,"startTime":"0","endTime":"0","summary":"证券之星消息,桂林三金(002275)05月26日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2025年5月20日A股股东人数是多少?谢谢桂林三金回复:您好,截至2025年05月20日股东总户数为18041,谢谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052600013792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0028","002275","BK0188"],"gpt_icon":0},{"id":"2535336719","title":"桂林三金:王许飞先生在桂林三金的任职已任期届满离任","url":"https://stock-news.laohu8.com/highlight/detail?id=2535336719","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535336719?lang=zh_cn&edition=full","pubTime":"2025-05-16 12:09","pubTimestamp":1747368546,"startTime":"0","endTime":"0","summary":"证券之星消息,桂林三金(002275)05月16日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司24Q3报告中,总裁是王许飞;24年报中,王许飞已不见踪影;中间公司的公告中未提及相关人员的变化,请问王总是离职了,还是有其他原因,谢谢。桂林三金回复:您好,三金集团为上市公司桂林三金的控股股东,目前王许飞先生担任三金集团董事、总裁。王许飞先生在桂林三金的任职,已经于2022年12月27日任期届满离任,相关信息在2022年年度报告中有详细披露,谢谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051600015354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","002275","BK0188","BK0028","BK0239"],"gpt_icon":0},{"id":"2535336740","title":"桂林三金:王许飞已于2022年12月27日任期届满离任上市公司职务","url":"https://stock-news.laohu8.com/highlight/detail?id=2535336740","media":"金融界","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535336740?lang=zh_cn&edition=full","pubTime":"2025-05-16 12:08","pubTimestamp":1747368516,"startTime":"0","endTime":"0","summary":"金融界5月16日消息,有投资者在互动平台向桂林三金提问:请问公司24Q3报告中,总裁是王许飞;24年报中,王许飞已不见踪影;中间公司的公告中未提及相关人员的变化,请问王总是离职了,还是有其他原因,谢谢。公司回答表示:您好,三金集团为上市公司桂林三金的控股股东,目前王许飞先生担任三金集团董事、总裁。王许飞先生在桂林三金的任职,已经于2022年12月27日任期届满离任,相关信息在2022年年度报告中有详细披露,谢谢。\n\n\r\n 责任编辑:栎树","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/16120850438984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0060","BK0028","002275","BK0239","BK0188"],"gpt_icon":0},{"id":"2534021159","title":"桂林三金:5月9日进行路演,平安证券、东方证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2534021159","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534021159?lang=zh_cn&edition=full","pubTime":"2025-05-12 16:35","pubTimestamp":1747038933,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年5月10日桂林三金发布公告称公司于2025年5月9日进行路演,平安证券、东方证券、华创证券、信达澳亚基金、永赢基金参与。基药目录公布时间由国家相关部门根据调整工作开展情况公布,目前国家暂未宣布新版基药目录公布时间。桂林三金主营业务:中成药的研发、制造与销售。融资融券数据显示该股近3个月融资净流出2637.19万,融资余额减少;融券净流入4.91万,融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051200021171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","BK1564","002275","600958","161027","BK0012","BK0060","BK1147","BK0188","BK0183","BK0239","BK0028","03958"],"gpt_icon":0},{"id":"2533508556","title":"桂林三金(002275)4月30日股东户数1.78万户,较上期增加0.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533508556","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533508556?lang=zh_cn&edition=full","pubTime":"2025-05-06 17:20","pubTimestamp":1746523249,"startTime":"0","endTime":"0","summary":"证券之星消息,近日桂林三金披露,截至2025年4月30日公司股东户数为1.78万户,较4月18日增加108.0户,增幅为0.61%。在中药行业个股中,桂林三金股东户数低于行业平均水平,截至4月30日,中药行业平均股东户数为5.23万户。从股价来看,2025年4月18日至2025年4月30日,桂林三金区间涨幅为0.37%,在此期间股东户数增加108.0户,增幅为0.61%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050600023605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","BK0239","002275","BK0188"],"gpt_icon":0},{"id":"2533058503","title":"桂林三金最新公告:控股孙公司BC006单抗注射液新增适应症获得药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2533058503","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533058503?lang=zh_cn&edition=full","pubTime":"2025-05-05 16:10","pubTimestamp":1746432623,"startTime":"0","endTime":"0","summary":"桂林三金(002275.SZ)公告称,公司控股孙公司宝船生物医药科技(上海)有限公司收到国家药品监督管理局核准签发的BC006单抗注射液的临床试验批件,同意本品开展用于特发性肺纤维化适应症的临床试验。该药品此前已获得晚期恶性肿瘤的临床试验批件,目前处于I期临床试验进行中。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050500001409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK1141","BK0188","BK0060","002275","BK1583","03347","BK1576"],"gpt_icon":0},{"id":"2533035623","title":"桂林三金(002275.SZ):BC006单抗注射液新增适应症获药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2533035623","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533035623?lang=zh_cn&edition=full","pubTime":"2025-05-05 15:57","pubTimestamp":1746431878,"startTime":"0","endTime":"0","summary":"桂林三金(002275.SZ)公告,公司控股孙公司宝船生物医药科技(上海)有限公司...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/11.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/11.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289215.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1576","03347","BK1583","002275","BK0060","BK0188","BK0239","BK1141","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752214693174,"stockEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":-0.0204},{"period":"3month","weight":0.1119},{"period":"6month","weight":0.1471},{"period":"1year","weight":0.2599},{"period":"ytd","weight":0.0087}],"compareEarnings":[{"period":"1week","weight":0.014},{"period":"1month","weight":0.0369},{"period":"3month","weight":0.0838},{"period":"6month","weight":0.1077},{"period":"1year","weight":0.194},{"period":"ytd","weight":0.0471}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"桂林三金药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"18764人(较上一季度增加3.69%)","perCapita":"29793股","listingDate":"2009-07-10","address":"广西壮族自治区桂林市临桂区人民南路9号","registeredCapital":"58756万元","survey":" 桂林三金药业股份有限公司的主营业务是中成药的研发、制造与销售,同时涵盖化学药品、生物药、日化健康与大健康等多个细分行业。公司的主要产品是三金片、三金颗粒、桂林西瓜霜、西瓜霜润喉片、西瓜霜清咽含片、桂林西瓜霜含片、舒咽清喷雾剂、桂林西瓜霜胶囊、脑脉泰胶囊、眩晕宁片、眩晕宁颗粒、蛤蚧定喘胶囊、复方田七胃痛胶囊、复方田七胃痛片、三七血伤宁胶囊、三七血伤宁散、复方罗汉果清肺颗粒、复方罗汉果清肺糖浆、复方红根草片、双虎肿痛宁、肝肾补颗粒、玉叶解毒颗粒。经过50多年的发展,公司质量管理体系已趋成熟,先后九次通过了澳大利亚TGA的认证复审,下属子公司均已完成新版GMP/GSP认证,并建立了覆盖全国的营销体系,公司药品质量安全可靠,产品竞争优势明显,市场空间广阔,为公司持续稳定发展夯实基础。","listedPrice":19.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"桂林三金(002275)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供桂林三金(002275)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"桂林三金,002275,桂林三金股票,桂林三金股票老虎,桂林三金股票老虎国际,桂林三金行情,桂林三金股票行情,桂林三金股价,桂林三金股市,桂林三金股票价格,桂林三金股票交易,桂林三金股票购买,桂林三金股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"桂林三金(002275)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供桂林三金(002275)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}